Navigation Links
Red Wine: One Drink A Day, Keeps Alzheimer's At Bay!

Animal research has once again offered a valuable insight for one of the leading mental illnesses in the World Today – Alzheimer's disease. // Red wine has always hogged a fair share of the limelight, with its perceived benefits to the heart and brain. A recent study seems to suggest that Red wine may be the elixir that mental health researchers have been looking for!

The researchers, from Mount Sinai School of Medicine, studied Mice, which were portraying alterations in the brain akin to Alzheimer's. The mice were fed with doses of Cabernet Sauvignon. It was observed that benefits of red wine was noticeably higher than the effects of ethanol or water; the mice showed remarkable reduction in the trademark alterations associated with memory in Alzheimer's disease.Indeed, Cabernet Sauvignon's contribution is crucial, preventing plaque accumulation in the brain, a distinguishing feature in the development of Alzheimer’s.

Researchers Dr. Giulio Maria Pasinetti and Dr. Jun Wang said "This study supports epidemiological evidence indicating that moderate wine consumption, within the range recommended by the FDA dietary guidelines of one drink per day for women and two for men, may help reduce the relative risk for AD clinical dementia."

Despite this finding, the time is not ripe for a carte blanche prescription of this remedy on humans. Threadbare Clinical trials on humans will prove if the perceived goodness of red-wine on Alzheimer's actually holds water.
SA
'"/>




Page: 1

Related medicine news :

1. Red Wine: Is It A Cure For Periodontal Disease?
2. Kick Smoking with Nicotine Drink
3. Drinking arsenic water leads to cancer
4. Drink grape juice for health
5. Drink milk right now
6. Drink alcohol for intelligence
7. Alcoholism Drug Fails To Prevent Drinking Relapses
8. Weight-Loss Drinks Can Make You Gassy
9. Heavy Drinking Raises Risk of Liver Cancer
10. Drinkers and smokers are at risk
11. Drink more fluids during exercise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ... animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at ... and joint health in horses at the immunologic level. , The scientifically-developed Flexadin ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the ... Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than ... marketer in the last 25 years. , Now, due to changes in the broadcast ...
(Date:4/24/2017)... Virginia (PRWEB) , ... April 24, 2017 , ... ... announced that they are seeking public support to bring their novel lifesaving device ... appearance, wearable device packed with medical-grade sensors, specially designed to read a child’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
Breaking Medicine Technology: